41
Participants
Start Date
April 2, 2013
Primary Completion Date
June 3, 2016
Study Completion Date
March 19, 2026
Ibrutinib
Given PO
Laboratory Biomarker Analysis
Correlative studies
Fox Chase Cancer Center, Philadelphia
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Metro Minnesota Community Oncology Research Consortium, Saint Louis Park
Park Nicollet Clinic - Saint Louis Park, Saint Louis Park
Mayo Clinic in Rochester, Rochester
Washington University School of Medicine, St Louis
Mayo Clinic in Arizona, Scottsdale
National University Hospital Singapore, Singapore
National Cancer Centre Singapore, Singapore
Mayo Clinic in Florida, Jacksonville
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Kingston Health Sciences Centre, Kingston
University Health Network-Princess Margaret Hospital, Toronto
National Cancer Institute (NCI)
NIH